Description
LL-37, human cathelicidin — 1 mg, ≥98 % HPLC — research overview
LL-37 is the only human cathelicidin antimicrobial peptide, derived by proteolytic cleavage of hCAP-18. It is the most widely cited reference compound in antimicrobial-peptide and innate-immunity research.
Peptide Shop supplies LL-37 (1 × 1 mg vial) as a sealed research material with lot-level documentation. This product is supplied for in-vitro laboratory research only and is not intended for human use, veterinary use, therapy, diagnosis, cosmetic application or consumption.
Research applications
- Antimicrobial peptide (AMP) research and MIC determination
- Innate-immunity and host-defence studies
- Endotoxin (LPS) neutralisation research
- Wound-closure and re-epithelialisation assay models
- Inflammation, chemotaxis and biofilm-disruption assays
Sequence and analytical data
Identity confirmed by ESI-MS ([M+H]+ = 4494.3). Highly cationic and amphipathic; uses low-binding tubes recommended.
Storage and handling
Store lyophilised at -20 °C protected from light. Reconstitute in sterile water or 0.01% acetic acid; avoid contact with serum proteins which bind LL-37 strongly.
Documentation
A lot-specific Certificate of Analysis is available in EN, DE, FR and ES from the product detail page after dispatch. The CoA reports HPLC purity, identity confirmation, appearance, and storage and handling guidance for the dispatched lot.
